Auto-generated: May 22 2012 06:50 AM GMT-8

243
Stars
Star This?

Source: DGNews  |  Posted 8 years ago

Remicade (Infliximab) Gains European Approval for Maintenance Dosing In Treatment of Fistulizing Crohn's Disease

KENILWORTH, NJ -- October 23, 2003 -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission has granted a European Union (EU) approval of Remicade

243
Stars
Star This?  Yes / No
 
Sign InSign In
inst val